Helen M. Thackray

2015 - GlycoMimetics

In 2015, Helen M. Thackray earned a total compensation of $854.5K as Chief Medical Officer at GlycoMimetics, a 24% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$113,065
Option Awards$361,390
Salary$380,050
Total$854,505

Thackray received $380.1K in salary, accounting for 44% of the total pay in 2015.

Thackray also received $113.1K in non-equity incentive plan and $361.4K in option awards.

Rankings

In 2015, Helen M. Thackray's compensation ranked 8,696th out of 13,638 executives tracked by ExecPay. In other words, Thackray earned more than 36.2% of executives.

ClassificationRankingPercentile
All
8,696
out of 13,638
36th
Division
Manufacturing
3,323
out of 5,190
36th
Major group
Chemicals And Allied Products
1,213
out of 1,854
35th
Industry group
Drugs
986
out of 1,528
36th
Industry
Pharmaceutical Preparations
771
out of 1,182
35th
Source: SEC filing on April 20, 2017.

Thackray's colleagues

We found three more compensation records of executives who worked with Helen M. Thackray at GlycoMimetics in 2015.

2015

Rachel King

GlycoMimetics

Chief Executive Officer

2015

John Magnani

GlycoMimetics

Chief Scientific Officer

2015

Brian Hahn

GlycoMimetics

Chief Financial Officer

News

You may also like